WHOLE SHINE MEDICAL 2026 H1 Performance Forecast: Oral Business Profitability Improves, Net Profit Attributable to Shareholders of the Parent Company Loss Narrows by Approximately 24%-50% Year-on-Year

Source: Haochen Medical 2026 Semi-Annual Performance Forecast

DentalGoodNews｜On July 14, 2026, WHOLE SHINE MEDICAL TECHNOLOGY CO.,LTD. (hereinafter referred to as "WHOLE SHINE MEDICAL") released its 2026 semi-annual performance forecast, disclosing the preliminary performance range for the period from January 1, 2026, to June 30, 2026. The company expects a net loss attributable to shareholders of the parent company (Net Profit Attributable to Shareholders of the Parent Company) of RMB 18.00 million to RMB 12.00 million, narrowing by RMB 5.75 million to RMB 11.75 million compared to the loss of RMB 23.7511 million in the same period last year, representing a year-on-year reduction of approximately 24% to 50%.

The net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses (Non-recurring Gains and Losses) is expected to be a loss of RMB 19.00 million to RMB 13.00 million, compared to a loss of RMB 23.5585 million in the same period last year. Basic earnings per share are expected to be a loss of RMB 0.0214 per share to RMB 0.0143 per share, compared to a loss of RMB 0.0283 per share in the same period last year. Based on the forecast range, both ends of the loss range for net profit after deducting non-recurring gains and losses are RMB 1 million higher than the net profit attributable to shareholders of the parent company. The announcement did not disclose specific items of non-recurring gains and losses.

The announcement shows that during the reporting period, the company's Oral and Dental medical service business and permanent magnet switch business showed divergent performance: the revenue scale of the Oral and Dental medical service business increased slightly year-on-year, with improved profitability in the segment; the permanent magnet switch business was affected by market environment factors, with weak overall demand in the industry, reduced customer order volumes, a year-on-year decline in revenue, and a corresponding decline in profitability.

Source: Haochen Medical 2025 Annual Report

According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), WHOLE SHINE MEDICAL's 2025 annual report disclosed in April this year showed that the company's full-year operating revenue in 2025 was RMB 703 million, a year-on-year decrease of 18.42%, with a full-year net loss attributable to shareholders of the parent company of RMB 119 million, expanding by 216.85% year-on-year. Among this, revenue from Oral and Dental medical services was RMB 638 million, down 17.54% year-on-year, and its core subsidiary, Delun Medical, turned from profit to loss, with a net loss of RMB 17.6013 million.

Source: Haochen Medical 2025 Annual Report

In June this year, the Shanghai Financial Court initiated a recovery enforcement procedure against WHOLE SHINE MEDICAL for approximately RMB 361 million, and the company has accrued estimated liabilities of over RMB 215 million. The 51% equity stake in Delun Medical held by its subsidiary Zhiyu Medical is under judicial freeze due to a loan dispute.

Additionally, WHOLE SHINE MEDICAL noted in the announcement that, as of now, key associated enterprises have not yet provided the company with their financial statements as of the end of June 2026. The company will continue to maintain communication with these associated enterprises and fulfill its information disclosure obligations in a timely manner in accordance with relevant laws and regulations. The data in this performance forecast are only estimates and have not been pre-audited by certified public accountants. The specific financial data shall be subject to the company's disclosed 2026 semi-annual report.